Open Access
| Issue |
BIO Web Conf.
Volume 124, 2024
The 2nd International Conference on Food Science and Bio-medicine (ICFSB 2024)
|
|
|---|---|---|
| Article Number | 02014 | |
| Number of page(s) | 9 | |
| Section | Biomedical and Clinical Medical Research | |
| DOI | https://doi.org/10.1051/bioconf/202412402014 | |
| Published online | 23 August 2024 | |
- Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. [J], 176(8):753–760. [Google Scholar]
- Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health. [J], 2018, 391(10131):1706–1717. [Google Scholar]
- Zhu B, Wang Y, Ming J, et al. Disease burden of COPD in China: a systematic review. [J], 2018, 13: 1353–1364. [Google Scholar]
- Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. [J], 2018, 391(10131): 1706–1717. [Google Scholar]
- Guo P, Li, R., Piao, T.H., Wang, Chun Lan., & Wu, Xiao Lu.. (2022). Pathological Mechanism and Targeted Drugs of COPD. International journal of chronic obstructive pulmonary disease. [Google Scholar]
- Silverman, Edwin K, Genetics of COPD. Annual review of physiology. 2019, [J], 82:413–431. [Google Scholar]
- Zhou-Suckow, Z., Duerr, J., Hagner, M., et al. Airway mucus, inflammation and remodeling: Emerging links in the pathogenesis of chronic lung diseases[J], 2017, 367 (3) : 537–550. NE [Google Scholar]
- Genschmer KR, Russell DW, Lal C, et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung. Cell. [J], 2019; 176(1-2):113–126. [CrossRef] [Google Scholar]
- Wang Z, Locantore N, Haldar K, et al. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am J Respir Crit Care Med. 2021; 203(12):1488–1502. [CrossRef] [PubMed] [Google Scholar]
- Roy MG, Livraghi-Butrico A, Fletcher AA, et al. Muc5b is required for airway defence. Nature. 2014; 505(7483):412–416. [CrossRef] [PubMed] [Google Scholar]
- Samsuzzaman M, Uddin MS, Shah MA, Mathew B. Natural inhibitors on airway mucin: molecular insight into the therapeutic potential targeting MUC5AC expression and production. Life Sci. 2019;231:116485. [CrossRef] [Google Scholar]
- Wu YF, Li ZY, Dong LL, et al. Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation. Autophagy. 2020; 16(3):435–450. [CrossRef] [PubMed] [Google Scholar]
- Mizumura K, Maruoka S, Shimizu T, Gon Y. Role of Nrf2 in the pathogenesis of respiratory diseases. Respir Investig. 2020;58(1):28–35. [Google Scholar]
- Jobst B J, Weinheimer O, Buschulte T, et al. Longitudinal airway remodeling in active and past smokers in a lung cancer screening population. [J], 2019, 29 (6) : 2968–2980. [Google Scholar]
- e-Lacerda, R.R., Anhe, G.F., Page, C.P., et al. Sex differences in the influence of obesity on a murine model of allergic lung inflammation. [J], 2020, 50 (2) : 256–266. [Google Scholar]
- Persson L J P, Aanerud M, Hardie J A, et al. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. [J], 2017, 49 (3) : 1601328 [Google Scholar]
- Zhou J S, Li Z Y, Xu X C, et al. Cigarette smoke- initiated autoimmunity facilitates sensitisation to elastin-induced COPD like pathologies in mice.[J], 2020, 56 (3) : 1. [Google Scholar]
- Zhang Y, Li Y, Ye, Z., et al. Expression of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and changes in alveolar septa in patients with chronic obstructive pulmonary disease. [J], 2020, 26: 925278–1. [Google Scholar]
- Hirota N, Martin J G. Mechanisms of airway remodeling. [J], 2013, 144 (3) : 1026–1032. [Google Scholar]
- Cotton S, Devereux G, Abbas H, et al. Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD).[J], 2022, 23(1): 307. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.